🇺🇸 Interferon-Alpha in United States

695 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 695

Most-reported reactions

1. Hepatic Failure — 184 reports (26.47%)
2. Drug Ineffective — 94 reports (13.53%)
3. Anaemia — 76 reports (10.94%)
4. Rash — 60 reports (8.63%)
5. Hepatitis C — 59 reports (8.49%)
6. Fatigue — 54 reports (7.77%)
7. Nausea — 50 reports (7.19%)
8. Thrombocytopenia — 43 reports (6.19%)
9. Asthenia — 39 reports (5.61%)
10. Pyrexia — 36 reports (5.18%)

Source database →

Frequently asked questions

Is Interferon-Alpha approved in United States?

Interferon-Alpha does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Interferon-Alpha in United States?

University of Birmingham is the originator. The local marketing authorisation holder may differ — check the official source linked above.